QA: Salarius Pharmaceuticals Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001615219_2022_Salarius_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001615219, Salarius Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 30,163,595
1 IntangibleAssetsNetIncludingGoodwill 8,865,909
2 PropertyPlantAndEquipmentNet 7,880
3 remainder_Assets 1,796,484
4 LiabilitiesCurrent 1,543,096
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 567,787
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,104,627
9 ResearchAndDevelopmentExpense 8,548,520
10 remainder_Expenses -44,693
11 remainder_Revenues 1,840,216
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 40,833,868
1 Liabilities 2,110,883
2 Expenses 14,608,454
3 Revenues 1,840,216
4 StockholdersEquity 38,722,985
5 NetIncome -12,768,238
6 ComprehensiveNetIncome -12,768,238
7 BaseVar 29,696,710
8 EconomicCapitalRatio 2.51

Edgar->Model Mapping

Feature Distribution

Change over Time